biomarker detection
I-Mab Begins Study of Uliledlimab Plus Tecentriq in Advanced Solid Tumors
The firm will evaluate the combination's efficacy and potential biomarkers of response in patients with ovarian cancer, head and neck cancer, NSCLC, TNBC, and other cancers.
Geneseeq Multi-Biomarker Approach Predicts EGFR-Mutated NSCLC Patients' Adjuvant Therapy Benefit
Premium
Geneseeq collaborated with researchers in China to generate three molecularly defined subgroups to guide adjuvant NSCLC treatment with either TKIs or chemotherapy.
LXRepair, Gustave Roussy Ink Research Partnership in Personalized Radiotherapy
The French biotech and cancer center have launched a joint lab to advance LXRepair's DNA-based functional assays to predict patients' responses to radiation.
Real-World Data from OneOncology, Roche Shed Light on NSCLC NGS Trends in Community Practices
Premium
The percentage of NSCLC patients undergoing biomarker testing has increased in recent years, but turnaround time and socioeconomic disparities need addressing.
ESMO Oncologists Debate Optimal Timing for Broad NGS, Align on Key Barriers to Precision Oncology
Premium
Oncologists argued for and against comprehensive NGS at the point of diagnosis but agreed on the need to address quality and cost barriers first.